Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Summary

This phase II trial studies how well temsirolimus works in treating patients with endometrial cancer that has spread to other parts of the body or has spread from where it started to nearby tissue or lymph nodes and has come back after a period of time during which the cancer could not be detected. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2004-05

Primary completion

2009-05

Completion

2009-08

Drugs

Indications